Literature DB >> 8560301

Developing outcome measures for ambulatory care--an application to asthma and diabetes.

E McColl1, I N Steen, K A Meadows, A Hutchinson, M P Eccles, J Hewison, P Fowler, S M Blades.   

Abstract

Increasing emphasis is now being placed on the assessment of patient outcomes, both in evaluating medical interventions and in quality assurance initiatives. Clinicians, purchasers, managers and researchers need outcome measures that are valid, reliable and responsive. This paper describes the theory and practice underlying the development of outcome measures for two chronic conditions, asthma and diabetes, for application in ambulatory settings. Existing generic and condition-specific health status and health-related quality-of-life measures were administered to almost 1300 patients. The psychometric properties of these measures were examined to identify those that were of adequate validity and reliability in these population groups. Step-wise regression procedures were then used to identify a core set of scales that best predicted patients' general health perceptions, which could be used in measuring general health outcomes for each of these groups. These core sets consist of up to 40 items, spanning physical function, energy and vitality, emotional well-being and condition-specific aspects of health such as symptom control. Further analysis is being carried out to assess the responsiveness to change of these core item sets.

Entities:  

Mesh:

Year:  1995        PMID: 8560301     DOI: 10.1016/0277-9536(95)00120-v

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  8 in total

1.  The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL.

Authors:  C Bradley; C Todd; T Gorton; E Symonds; A Martin; R Plowright
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

2.  A new self-completion outcome measure for diabetes: is it responsive to change?

Authors:  P Whitty; N Steen; M Eccles; E McColl; J Hewison; K Meadows; Z Clapp; A Hutchinson
Journal:  Qual Life Res       Date:  1997-07       Impact factor: 4.147

3.  The Diabetes Health Profile (DHP): a new instrument for assessing the psychosocial profile of insulin requiring patients--development and psychometric evaluation.

Authors:  K Meadows; N Steen; E McColl; M Eccles; C Shiels; J Hewison; A Hutchinson
Journal:  Qual Life Res       Date:  1996-04       Impact factor: 4.147

4.  Attitudes to the use of health outcome questionnaires in the routine care of patients with diabetes: a survey of general practitioners and practice nurses.

Authors:  K A Meadows; D Rogers; T Greene
Journal:  Br J Gen Pract       Date:  1998-09       Impact factor: 5.386

5.  The validity and reliability of the Diabetes Health Profile (DHP) in NIDDM patients referred for insulin therapy.

Authors:  P Goddijn; H Bilo; K Meadows; K Groenier; E Feskens; B Meyboom-de Jong
Journal:  Qual Life Res       Date:  1996-08       Impact factor: 4.147

6.  Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control.

Authors:  Charlene C Quinn; Michelle D Shardell; Michael L Terrin; Erik A Barr; Shoshana H Ballew; Ann L Gruber-Baldini
Journal:  Diabetes Care       Date:  2011-07-25       Impact factor: 19.112

7.  A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial.

Authors:  Martin P Eccles; Paula M Whitty; Chris Speed; Ian N Steen; Alessandra Vanoli; Gillian C Hawthorne; Jeremy M Grimshaw; Linda J Wood; David McDowell
Journal:  Implement Sci       Date:  2007-02-16       Impact factor: 7.327

8.  A randomised controlled trial of a patient based Diabetes Recall and Management System: the DREAM trial: a study protocol [ISRCTN32042030].

Authors:  Martin Eccles; Gillian Hawthorne; Paula Whitty; Nick Steen; Alessandra Vanoli; Jeremy Grimshaw; Linda Wood
Journal:  BMC Health Serv Res       Date:  2002-03-21       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.